RT Journal Article
SR Electronic
T1 Cardiac imaging of aortic valve area from 26,142 UK Biobank participants reveal novel genetic associations and shared genetic comorbidity with multiple disease phenotypes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.09.20060012
DO 10.1101/2020.04.09.20060012
A1 Aldo Córdova-Palomera
A1 Catherine Tcheandjieu
A1 Jason Fries
A1 Paroma Varma
A1 Vincent S. Chen
A1 Madalina Fiterau
A1 Ke Xiao
A1 Heliodoro Tejeda
A1 Bernard Keavney
A1 Heather J. Cordell
A1 Yosuke Tanigawa
A1 Guhan Venkataraman
A1 Manuel Rivas
A1 Christopher Ré
A1 Euan Ashley
A1 James R. Priest
YR 2020
UL http://medrxiv.org/content/early/2020/04/14/2020.04.09.20060012.abstract
AB The aortic valve is an important determinant of cardiovascular physiology and anatomic location of common human diseases. From a sample of 26,142 European-ancestry participants, we estimated functional aortic valve area by planimetry from prospectively obtained cardiac MRI sequences of the aortic valve. A genome-wide association study of aortic valve area in these UK Biobank participants showed two significant associations indexed by rs71190365 (chr13:50764607, DLEU1, p=1.8×10−9) and rs35991305 (chr12:94191968, CRADD, p=3.4×10−8). From the GWAS findings we constructed a polygenic risk score for aortic valve area, which in a separate cohort of 311,728 individuals without imaging demonstrated that smaller aortic valve area is predictive of increased risk for aortic valve disease (Odds Ratio 0.88, p=2.3×10−6). After excluding subjects with a medical diagnosis of aortic valve stenosis (remaining n=310,546 individuals), phenome-wide association of >10,000 traits showed multiple links between the polygenic score for aortic valve disease and key health-related comorbidities involving the cardiovascular system and autoimmune disease. Genetic correlation analysis supports a shared genetic etiology with between aortic valve size and birthweight along with other cardiovascular conditions. These results illustrate the use of automated phenotyping of cardiac imaging data from the general population to investigate the genetic etiology of aortic valve disease, perform clinical prediction, and uncover new clinical and genetic correlates of cardiac anatomy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by the National Institutes of Health (R00HL130523). The authors or their institutions have not received payment or services from a third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUK Biobank clinical & imaging data is available to any qualified researcher at https://www.ukbiobank.ac.uk/